Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Mar;15(3):269-72.
doi: 10.1089/dia.2012.0251. Epub 2013 Jan 23.

Verification of skin autofluorescence values by mass spectrometry in adolescents with type 1 diabetes: brief report

Affiliations
Case Reports

Verification of skin autofluorescence values by mass spectrometry in adolescents with type 1 diabetes: brief report

Emília Mácsai et al. Diabetes Technol Ther. 2013 Mar.

Abstract

Background: Accumulation of advanced glycation end products (AGEs) in tissues is a major risk factor for diabetes-associated complications. Skin autofluorescence (SAF) values measured by a specific noninvasive approach (AGE Reader; DiagnOptics Technologies B.V., Gröningen, The Netherlands) reflect the overall AGE exposure in skin.

Subjects and methods: In 16 adolescents with type 1 diabetes (age range, 11-18 years) we tested the association between SAF measured with an AGE Reader and the presence of glucuronic acid, 3-indoxyl sulfate, 3-hydroxybutyrate, phenol sulfate, and pentosidine in skin tissue determined with desorption electrospray ionization mass spectrometry (DESI-MS). These compounds are implicated in long-term diabetes complications.

Results: SAF values significantly correlated with levels of compounds measured by DESI-MS (r>0.9 and P<0.001 for each).

Conclusions: The strong correlation between adolescents' SAF values measured with the AGE Reader and some glycation products measured with DESI-MS indicates that SAF values may be used as surrogate markers of skin exposure to glycemic end products in type 1 diabetes.

PubMed Disclaimer

Substances

LinkOut - more resources